Pathogenic fungi: Difference between revisions
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +)) |
||
Line 32: | Line 32: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
Latest revision as of 13:42, 6 September 2012
WikiDoc Resources for Pathogenic fungi |
Articles |
---|
Most recent articles on Pathogenic fungi Most cited articles on Pathogenic fungi |
Media |
Powerpoint slides on Pathogenic fungi |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Pathogenic fungi at Clinical Trials.gov Trial results on Pathogenic fungi Clinical Trials on Pathogenic fungi at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Pathogenic fungi NICE Guidance on Pathogenic fungi
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Pathogenic fungi Discussion groups on Pathogenic fungi Patient Handouts on Pathogenic fungi Directions to Hospitals Treating Pathogenic fungi Risk calculators and risk factors for Pathogenic fungi
|
Healthcare Provider Resources |
Causes & Risk Factors for Pathogenic fungi |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Pathogenic fungi are fungi that cause disease in humans or other organisms. The study of pathogenic fungi is referred to as medical mycology. Although fungi are eukaryotic organisms many pathogenic fungi are also microorganisms.[1]
Candida
Candida species are important human pathogens that are best known for causing opportunist infections in immunocompromised hosts (eg transplant patients, AIDS sufferers, cancer patients). Infections are difficult to treat and can be very serious: 30-40% of systemic infections result in death. The sequencing of the genome of C. albicans and those of several other medically-relevant Candida species has provided a major impetus for Candida comparative and functional genomic analyses. These studies are aiding the development of sensitive diagnostic strategies and novel antifungal therapies.[2]
Aspergillus
Some Aspergillus species are pathogenic and can cause serious disease in humans and animals. The most common pathogenic species are Aspergillus fumigatus and Aspergillus flavus. Aspergillus flavus produces aflatoxin which is both a toxin and a carcinogen and which can potentially contaminate foods such as nuts. Aspergillus fumigatus and Aspergillus clavatus can cause allergic disease. Some Aspergillus spp. cause disease on grain crops, especially maize, and synthesize mycotoxins including aflatoxin. Aspergillosis is the group of diseases caused by Aspergillus. The symptoms include fever, cough, chest pain or breathlessness. Usually, only patients with weakened immune systems or with other lung conditions are susceptible.[1]
Cryptococcus
Cryptococcus neoformans can cause a severe form of meningitis and meningo-encephalitis in patients with HIV infection and AIDS. The majority of Cryptococcus species live in the soil and do not cause disease in humans. Cryptococcus neoformans is the major human and animal pathogen. Cryptococcus laurentii and Cryptococcus albidus have been known to occasionally cause moderate-to-severe disease in human patients with compromised immunity. Cryptococcus gattii is endemic to tropical parts of the continent of Africa and Australia and can cause disease in non-immunocompromised people.[1]
Histoplasma
Histoplasma capsulatum can cause histoplasmosis in humans, dogs and cats. The fungus is most prevalent in the Americas, India and southeastern Asia. It is endemic in certain areas of the United States. Infection is usually due to inhaling contaminated air.
Pneumocystis
Pneumocystis jirovecii can cause a form of a form of pneumonia in people with weakened immune systems, such as premature children, the elderly, and AIDS patients.[3]
Stachybotrys
Stachybotrys chartarum or "black mold" can cause respiratory damage and severe headaches. It frequently occurs in houses in regions that are chronically damp.
Drug resistance
Treatment with antifungal drugs often results in the appearance of resistant strains of fungi. Various mechanisms leading to resistance have been described. For example, a number of resistant clinical isolates overexpress genes encoding drug efflux pumps. Recent advances in molecular biology have allowed the study of the phenomenon of multi-drug resistance on a genome-wide scale. DNA microarrays are being used to study the expression profiling of pathogenic fungi and proteomics is aiding research in the development of resistance to various antifungal drugs. [4]
See also
References
- ↑ 1.0 1.1 1.2 San-Blas G; Calderone RA (editors). (2008). Pathogenic Fungi: Insights in Molecular Biology. Caister Academic Press. ISBN 978-1-904455-32-5 .
- ↑ dEnfert C; Hube B (editors). (2007). Candida: Comparative and Functional Genomics. Caister Academic Press. ISBN 978-1-904455-13-4 .
- ↑ Ryan KJ; Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed. ed.). McGraw Hill. ISBN 0838585299.
- ↑ Waldin; et al. (2008). "Genome-wide Approaches to Understand Multi-drug Resistance in Pathogenic Fungi". Pathogenic Fungi: Insights in Molecular Biology. Caister Academic Press. ISBN 978-1-904455-32-5.